JEMPERLI 500 mg concentrate for solution for infusion
219885
Phase 2 small_molecule active
Quick answer
JEMPERLI 500 mg concentrate for solution for infusion for Neoplasms, Head and Neck is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Neoplasms, Head and Neck
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active